Page 94 - TD-3-4

Tumor Discovery RNA-protein complexes deregulated in cancer

doi: 10.1093/procel/pwad009 suppresses growth and metastasis of renal cell carcinoma
by decreasing long noncoding RNA NEAT1. Cancer Sci.
192. Hu J, Lin H, Wang C, Su Q, Cao B. METTL14-mediated
RNA methylation in digestive system tumors. Int J Mol Med. 2022;113:446-458.
2023;52(3):86. doi: 10.1111/cas.15212
doi: 10.3892/ijmm.2023.5289 203. Wei H, Huang L, Lu Q, et al. N6-methyladenosine-modified
LEAWBIH drives hepatocellular carcinoma progression
193. Wang J, Wang S, Yang H, et al. Methyltransferase like-
14 suppresses growth and metastasis of non-small- through epigenetically activating Wnt/β-catenin signaling.
cell lung cancer by decreasing LINC02747. Cancer Sci. J Hepatocellular Carcinoma. 2023;10:1991-2007.
2024;115(9):2931-2946. doi: 10.2147/JHC.S433070
doi: 10.1111/cas.16254 204. Bei M, Hao S, Lin K, et al. Splicing factor TRA2A contributes
to esophageal cancer progression via a noncanonical role in
194. Lee JH, Wang R, Xiong F, et al. Enhancer RNA m6A
methylation facilitates transcriptional condensate formation lncRNA m6 A methylation. Cancer Sci. 2023;114:3216-3229.
and gene activation. Mol Cell. 2021;81(16):3368-3385.e9. doi: 10.1111/cas.15870
doi: 10.1016/j.molcel.2021.07.024 205. Su T, Liu J, Zhang N, et al. New insights into the
interplay between m6A modifications and microRNA or
195. Long X, Wen F, Li J, Huang X. LncRNA FEZF1-AS1 accelerates
multiple myeloma progression by regulating IGF2BP1/ lncRNA in gastrointestinal cancers. Front Cell Dev Biol.
BZW2 signaling. Hematol Oncol. 2023;41(4):694-703. 2023;11:1157797.
doi: 10.3389/fcell.2023.1157797
doi: 10.1002/hon.3157
206. Hu X, Peng WX, Zhou H, et al. IGF2BP2 regulates DANCR
196. Shen W, Zhu M, Wang Q, et al. DARS-AS1 recruits
METTL3/METTL14 to bind and enhance DARS mRNA by serving as an N6-methyladenosine reader. Cell Death
m(6)A modification and translation for cytoprotective Differ. 2020;27(6):1782-1794.
autophagy in cervical cancer. RNA Biol. 2022;19:751-763. doi: 10.1038/s41418-019-0461-z
doi: 10.1080/15476286.2022.2079889 207. Xu Y, Weng X, Qiu J, Wang S. Biogenesis of circRBM33
mediated by N6-methyladenosine and its function in
197. Liu H, Xu Y, Yao B, Sui T, Lai L, Li Z. A novel
N6-methyladenosine (m6A)-dependent fate decision for the abdominal aortic aneurysm. Epigenetics. 2024;19(1):2392401.
lncRNA THOR. Cell Death Dis. 2020;11:613. doi: 10.1080/15592294.2024.2392401
doi: 10.1038/s41419-020-02833-y 208. Zhang Y, Chen Z, Song J, Qian H, Wang Y, Liang Z. The
role of m6A modified circ0049271 induced by MNNG
198. Ban Y, Tan P, Cai J, et al. LNCAROD is stabilized by m6A
methylation and promotes cancer progression via forming a in precancerous lesions of gastric cancer. Heliyon.
ternary complex with HSPA1A and YBX1 in head and neck 2024;10(16):e35654.
squamous cell carcinoma. Mol Oncol. 2020;14:1282-1296. doi: 10.1016/j.heliyon.2024.e35654
doi: 10.1002/1878-0261.12676 209. Liu F, Gu W, Shao Y. Cross-talk between circRNAs and m6A
modifications in solid tumors. J Transl Med. 2024;22(1):694.
199. Ni W, Yao S, Zhou Y, et al. Long noncoding RNA GAS5
inhibits the progression of colorectal cancer by interacting doi: 10.1186/s12967-024-05500-4
with and triggering YAP phosphorylation and degradation 210. Shu G, Zhao Z, Zhao T, et al. N6-methyladenosine
and is negatively regulated by the m6A reader YTHDF3. modification of circMARK2 enhances cytoplasmic export
Mol Cancer. 2019;18:143.
and stabilizes LIN28B, contributing to the progression of
doi: 10.1186/s12943-019-1079-y Wilms tumor. J Exp Clin Cancer Res. 2024;43(1):191.
200. Chen F, Li M, Wang L. LncRNA CASC11 promotes doi: 10.1186/s13046-024-03113-9
hepatocellular carcinoma progression via upregulation 211. Yankova E, Blackaby W, Albertella M, et al. Small-molecule
of UBE2T in a m6A-dependent manner. Front Oncol. inhibition of METTL3 as a strategy against myeloid
2021;11:772671.
leukemia. Nature. 2021;593:597-601.
doi: 10.3389/fonc.2021.772671
doi: 10.1038/s41586-021-03536-w
201. Zhang J, Guo S, Piao HY, et al. ALKBH5 promotes invasion 212. Fiorentino F, Menna M, Rotili D, Valente S, Mai A.
and metastasis of gastric cancer by decreasing methylation METTL3 from target validation to the first small-molecule
of the lncRNA NEAT1. J Physiol Biochem. 2019;75:379-389.
inhibitors: A medicinal chemistry journey. J Med Chem.
doi: 10.1007/s13105-019-00690-8 2023;66(3):1654-1677.
202. Liu T, Wang H, Fu Z, et al. Methyltransferase-like 14 doi: 10.1021/acs.jmedchem.2c01601

Volume 3 Issue 4 (2024) 35 doi: 10.36922/td.4657